From: Residential aged care residents and components of end of life care in an Australian hospital
Measures | Total | Advanced Dementia (AD) | Without Advanced Dementia (WAD) | AD vs WAD | |||
---|---|---|---|---|---|---|---|
 | Number (+/− %) | Mean (SD, Range) | Number (+/− %) | Mean (SD, Range) | Number (+/− %) | Mean (SD, Range) | p value |
For Admitted under SPC | 14 | Â | 1 | Â | 13 | Â | Â |
 PCU Length of Stay |  | 6.7 (8.4, 1.3–33.1) |  | 2.2 (N/A) |  | 7.0 (8.6, 1.3–33.1) |  |
For Admitted under Non SPC | 87 | Â | 21 | Â | 66 | Â | Â |
 SPC Advice Only | 4 (5) |  | 0 (0) |  | 4 (6) |  | p = 0.568 |
 SPC Consult Referral | 38 (44) |  | 10 (48) |  | 28 (42) |  | p = 0.676 |
 Patient Seen by SPC | 33 (38) |  | 10 (48) |  | 23 (35) |  |  |
 Patient Died Before Seen | 5 (6) |  | 0 (0) |  | 5 (8) |  |  |
 Any SPC Involvement | 42 (49) |  | 10 (48) |  | 32 (48) |  | p = 0.945 |
For SPC Consult | |||||||
 Days to be Seen |  | 0.6 (1.1, 0–3) |  | 0.6 (1, 0–3) |  | 0.6 (1.1, 0–3) |  |
 SPC Take Over | 18 (21) |  | 4 (19) |  | 13 (20) |  | p = 1.00 |
For PCU | |||||||
 Transfer to PCU | 32 (37) |  | 8 (38) |  | 24 (36) |  | p = 0.886 |
 PCU Length of Stay |  | 2.4 (2.6, 0–11.4) |  | 3.0 (1.4, 1.6–5.3) |  | 2.3 (2.9, 0–11.4) |  |
For All Patients (including Not Admitted) | |||||||
 Number of Family/Caregiver Goals of Care Discussions |  | 1.7 (1.0, 0–5) |  | 1.5 (0.5, 1–2) |  | 1.7 (1.1, 0–5) | p = 0.581 |
End of Life Medications in Last Three Days | |||||||
 Opioid Charted | 95 (87) |  | 20 (80) |  | 75 (89) |  |  |
 Opioid Dose(s) per Day |  | 2.5 (1.9, 0–8.7) |  | 2.4 (1.5, 0–5) |  | 2.6 (1.9, 0–8.7) |  |
 Antipsychotic Charted | 47 (43) |  | 9 (36) |  | 38 (45) |  |  |
 Antipsychotic Dose(s) per Day |  | 0.4 (0.7, 0–3) |  | 0.1 (0.2, 0–0.7) |  | 0.4 (0.7, 0–3) |  |
 Pure Antiemetic Charted | 51 (47) |  | 8 (32) |  | 43 (51) |  |  |
 Pure Antiemetic Dose(s) per Day |  | 0.3 (0.6, 0–3) |  | 0.5 (1.1, 0–3) |  | 0.3 (0.5, 0–2) |  |
 Benzodiazepine Charted | 80 (73) |  | 16 (70) |  | 63 (75) |  |  |
 Benzodiazepine Dose(s) per Day |  | 1.4 (1.5, 0–6.3) |  | 1.6 (1.3, 0–4) |  | 1.4 (1.6, 0–6.3) |  |
 Antisecretory Charted | 77 (71) |  | 17 (68) |  | 58 (69) |  |  |
 Antisecretory Dose(s) per Day |  | 1.0 (1.2, 0–5) |  | 1.1 (1.4, 0–4.3) |  | 0.9 (1.2, 0–5) |  |
 Total Doses per Day |  | 4.2 (3.5, 0–18) |  | 4.0 (3.3, 0–11.3) |  | 4.2 (3.6, 0–18) | p = 0.867 |
 CSCI Commenced | 38 (35) |  | 8 (32) |  | 30 (36) |  | p = 0.732 |